ATP7A and Parkinson disease: In contrast, in the comparison between stage IV and V Parkinson’s disease patients, probably due to the small sample size, only ATP7A was significantly different in the two groups (Figure 4B, p < 0.05), suggesting what seems to indicate their potential role in Parkinson’s onset and progression.